Your browser is no longer supported. Please, upgrade your browser.
Settings
IRIX IRIDEX Corporation daily Stock Chart
IRIX [NASD]
IRIDEX Corporation
Index- P/E7.92 EPS (ttm)0.87 Insider Own27.60% Shs Outstand10.00M Perf Week-3.64%
Market Cap68.90M Forward P/E- EPS next Y- Insider Trans4.22% Shs Float9.44M Perf Month-1.99%
Income8.80M PEG0.26 EPS next Q- Inst Own57.30% Short Float0.26% Perf Quarter-20.16%
Sales41.70M P/S1.65 EPS this Y340.90% Inst Trans-0.38% Short Ratio0.76 Perf Half Y-33.94%
Book/sh3.31 P/B2.08 EPS next Y- ROA22.30% Target Price10.00 Perf Year-13.01%
Cash/sh1.22 P/C5.65 EPS next 5Y30.00% ROE27.80% 52W Range6.41 - 11.28 Perf YTD-19.88%
Dividend- P/FCF31.32 EPS past 5Y43.40% ROI33.50% 52W High-38.90% Beta0.92
Dividend %- Quick Ratio3.10 Sales past 5Y6.70% Gross Margin49.60% 52W Low7.49% ATR0.33
Employees106 Current Ratio4.50 Sales Q/Q-15.10% Oper. Margin2.90% RSI (14)46.09 Volatility4.62% 5.24%
OptionableNo Debt/Eq0.00 EPS Q/Q-333.30% Profit Margin21.10% Rel Volume0.39 Prev Close6.72
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout0.00% Avg Volume32.15K Price6.89
Recom1.00 SMA20-0.32% SMA50-7.90% SMA200-22.29% Volume12,464 Change2.53%
Jan-03-07Initiated First Albany Buy $15.50
Aug-26-15 01:56PM  IRIDEX Corp. Earnings Q2, 2015
Aug-21-15 01:04PM  IRIDEX CORP Financials
Aug-20-15 05:01PM  Edited Transcript of IRIX earnings conference call or presentation 6-Aug-15 9:00pm GMT
Aug-12-15 08:12PM  10-Q for IRIDEX Corp. at Company Spotlight
Aug-10-15 05:44PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report -7.02%
Aug-06-15 05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:38PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 Second Quarter, Six-Month Results PR Newswire
10:37AM  Novadaq Technologies, Inc. Earnings Q2*, 2015
07:07AM  Q2 2015 IRIDEX Corp Earnings Release - After Market Close
Aug-04-15 04:32PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity PR Newswire
Jul-30-15 04:05PM  IRIDEX Announces Second Quarter 2015 Conference Call and Release Date PR Newswire
Jul-16-15 07:02AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -12.00%
06:30AM  IRIDEX Announces Preliminary Revenues for 2015 Second Quarter PR Newswire
Jun-19-15 04:14PM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-18-15 04:13AM  Edited Transcript of IRIX earnings conference call or presentation 7-May-15 9:00pm GMT
May-28-15 04:01PM  IRIDEX to Present at LD Micro Invitational PR Newswire
May-14-15 08:11PM  10-Q for IRIDEX Corp. at Company Spotlight
May-13-15 06:00AM  IRIDEX to Present at UBS Global Healthcare Conference PR Newswire
May-12-15 01:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
May-07-15 07:34PM  Iridex posts 1Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:37PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 First Quarter Results PR Newswire
07:07AM  Q1 2015 IRIDEX Corp Earnings Release - After Market Close
Apr-30-15 04:47PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date at noodls
04:05PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date PR Newswire
Apr-24-15 08:12PM  10-K for IRIDEX Corp. at Company Spotlight
Apr-16-15 06:30AM  IRIDEX' Total Glaucoma Solution Campaign for US Market to Debut at Annual Congress of the American Society of Cataract and Refractive Surgery PR Newswire +5.02%
Apr-02-15 04:55PM  IRIDEX CORP Files SEC form 10-K, Annual Report
Mar-30-15 06:38AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries at noodls
06:30AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries PR Newswire
Mar-17-15 06:41AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems at noodls
06:30AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems PR Newswire
Mar-09-15 05:13PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-05-15 06:31PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results at noodls -5.75%
06:03PM  Iridex posts 4Q profit
05:00PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:05PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results PR Newswire
07:07AM  Q4 2014 IRIDEX Corp Earnings Release - Time Not Supplied
Feb-26-15 04:26PM  IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date at noodls
04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date PR Newswire
Feb-23-15 06:30AM  IRIDEX To Debut Cyclo G6 Glaucoma Laser Platform and Present New Clinical Data at the American Glaucoma Society's Annual Meeting PR Newswire
Feb-02-15 06:30AM  IRIDEX Receives FDA Clearance for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma PR Newswire
Jan-15-15 04:04PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jan-14-15 06:01AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Jan-12-15 06:30AM  IRIDEX Announces Preliminary Unaudited Revenues for 2014 Fourth Quarter and Full Year; 2015 Revenue Outlook PR Newswire +6.41%
Dec-31-14 04:12PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Dec-02-14 06:30AM  IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions PR Newswire
Nov-19-14 06:30AM  IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment PR Newswire
Nov-05-14 07:08PM  10-Q for IRIDEX Corp. Company Spotlight
09:11AM  Iridex (IRIX) Upgraded From Hold to Buy at TheStreet
Nov-03-14 02:12PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-30-14 05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 Third Quarter, Nine-Month Results PR Newswire
07:07AM  Q3 2014 IRIDEX Corp Earnings Release - After Market Close CCBN
Oct-23-14 04:05PM  IRIDEX Announces Third Quarter 2014 Conference Call and Release Date PR Newswire
Oct-17-14 06:30AM  IRIDEX to Host MicroPulse┬« Worldwide 3-Day Forum at the American Academy of Ophthalmology PR Newswire
Oct-14-14 06:30AM  IRIDEX Expands Retinal Portfolio PR Newswire
Oct-07-14 06:30AM  IRIDEX Granted U.S. Patent for Disposable MicroPulse┬« Delivery Device for the Non-invasive Treatment of Glaucoma PR Newswire
Oct-01-14 04:05PM  IRIDEX Reports Strong Attendance at European Workshop for its Proprietary MicroPulse┬« Laser Therapy for Retina and Glaucoma Applications PR Newswire
Sep-26-14 06:02PM  Nasdaq stocks posting largest volume decreases AP
Aug-27-14 06:30AM  IRIDEX to Present at Robert W. Baird 2014 Health Care Conference PR Newswire
Aug-07-14 01:00PM  Director Garrett A. Garrettson, Ph.D. to Step Down After Decade-Long Service PR Newswire
Aug-05-14 04:05PM  IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference PR Newswire
Aug-04-14 04:06PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jul-31-14 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 Second Quarter, Six-Month Results PR Newswire
07:07AM  Q2 2014 IRIDEX Earnings Release - After Market Close CCBN
Jul-24-14 04:05PM  IRIDEX Announces Second Quarter 2014 Conference Call and Release Date PR Newswire
May-22-14 06:30AM  IRIDEX Announces New Multi-Center Study Data Demonstrates Safety, Durability of Proprietary MicroPulse Technology for Treatment of Glaucoma PR Newswire
May-05-14 04:36PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
May-04-14 02:43AM  IRIDEX's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
May-01-14 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:32PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 First Quarter Results PR Newswire
07:07AM  Q1 2014 IRIDEX Earnings Release - After Market Close CCBN
Apr-24-14 04:05PM  IRIDEX Announces First Quarter 2014 Conference Call and Release Date PR Newswire
Apr-22-14 06:30AM  IRIDEX Announces Proprietary MicroPulse Technology For Treatment Of Eye Diseases Caused By Diabetes And Age-Related Macular Degeneration Featured On 'American Health Front' Program PR Newswire
Apr-10-14 10:27AM  Low-Priced Stock Buys: New Treatments For Eye Disease, Respiratory Difficulties at Forbes
Mar-27-14 05:19PM  IRIDEX CORP Files SEC form 10-K, Annual Report EDGAR Online
Feb-27-14 09:00PM  IRIDEX Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2013 Fourth Quarter Results PR Newswire
07:07AM  Q4 2013 IRIDEX Earnings Release - After Market Close CCBN
Feb-20-14 04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2013 Conference Call and Release Date PR Newswire
Jan-29-14 05:23PM  IRIDEX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Jan-28-14 06:30AM  IRIDEX Announces Preliminary Unaudited Revenues For 2013 Fourth Quarter and Year End PR Newswire -5.35%
Jan-09-14 06:01AM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Dec-10-13 04:57PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Nov-28-13 10:00AM  Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside at Seeking Alpha
Nov-13-13 02:14PM  IRIDEX To Introduce Four New Products At Annual AAO Meeting PR Newswire +8.66%
Nov-07-13 06:30AM  IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales PR Newswire
Nov-06-13 11:28AM  Iridex - In The Early Innings Of Margin Expansion at Seeking Alpha
Nov-04-13 04:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online +9.95%
IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 21Buy7.188,85163,5501,175,788Aug 21 04:40 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 20Buy7.1610,30073,7481,166,937Aug 21 04:40 PM
Steckel RonaldVP, OperationsAug 19Option Exercise3.991,6846,71929,875Aug 20 05:36 PM
Mackaness James HCFO and COOAug 19Option Exercise4.311,8798,09846,931Aug 21 06:20 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 19Buy7.061,50010,5901,156,637Aug 21 04:40 PM
Mackaness James HCFO and COOAug 19Sale7.152,37316,96745,052Aug 21 06:20 PM
Steckel RonaldVP, OperationsAug 19Sale7.141,75112,49928,875Aug 20 05:36 PM
Mackaness James HCFO and COOAug 18Option Exercise4.312,0868,99146,517Aug 19 06:22 PM
Mackaness James HCFO and COOAug 18Sale7.102,62718,65844,531Aug 19 06:22 PM
Mackaness James HCFO and COOAug 17Option Exercise4.311,7797,66745,796Aug 19 06:22 PM
Mackaness James HCFO and COOAug 17Sale7.052,23515,75744,017Aug 19 06:22 PM
Mackaness James HCFO and COOAug 14Option Exercise4.312,2009,48245,761Aug 17 06:15 PM
Mackaness James HCFO and COOAug 14Sale7.052,76519,49343,531Aug 17 06:15 PM
Steckel RonaldVP, OperationsAug 14Sale7.001,0007,00028,942Aug 14 07:34 PM
Steckel RonaldVP, OperationsAug 13Option Exercise3.994001,59630,342Aug 14 07:34 PM
Mackaness James HCFO and COOAug 13Option Exercise4.314,00417,25747,000Aug 17 06:15 PM
Mackaness James HCFO and COOAug 13Sale6.955,00034,75042,996Aug 17 06:15 PM
Steckel RonaldVP, OperationsAug 13Sale7.004002,80029,942Aug 14 07:34 PM
Steckel RonaldVP, OperationsAug 12Sale7.005840629,942Aug 14 07:34 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 07Buy7.246,32445,7861,155,137Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 06Buy6.5640,210263,7781,148,813Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 05Buy6.6345,000298,3501,108,603Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerJul 24Buy6.9815,984111,5681,063,603Jul 27 05:29 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerJul 23Buy7.0324,419171,6661,047,619Jul 27 05:29 PM
FITCH SANFORDDirectorJun 26Option Exercise6.193,75023,21339,094Jun 29 06:31 PM
Steckel RonaldVP, OperationsJun 17Option Exercise3.941,6666,56431,041Jun 18 06:46 PM
Steckel RonaldVP, OperationsJun 17Sale8.771,66614,60630,000Jun 18 06:46 PM
Mackaness James HCFO and COOMay 20Option Exercise0.902,0001,80044,000May 21 07:19 PM
Mackaness James HCFO and COOMay 20Sale9.802,00019,60942,000May 21 07:19 PM
Steckel RonaldVP, OperationsMay 18Option Exercise3.941,6676,56831,042May 19 07:29 PM
Steckel RonaldVP, OperationsMay 18Sale9.331,66715,54730,000May 19 07:29 PM
Steckel RonaldVP, OperationsApr 20Sale9.791,44714,16630,000Apr 21 05:54 PM
Steckel RonaldVP, OperationsApr 17Option Exercise3.941,6676,56832,489Apr 20 05:28 PM
Steckel RonaldVP, OperationsApr 17Sale9.861,66716,43931,447Apr 20 05:28 PM
Steckel RonaldVP, OperationsMar 17Option Exercise3.9711,35845,13440,697Mar 18 06:39 PM
Steckel RonaldVP, OperationsMar 17Sale10.0811,358114,47730,714Mar 18 06:39 PM
Steckel RonaldVP, OperationsMar 10Sale10.031,25012,54330,714Mar 11 06:07 PM
Steckel RonaldVP, OperationsFeb 17Option Exercise3.941,6506,50032,989Feb 18 05:44 PM
Steckel RonaldVP, OperationsFeb 17Sale9.791,65016,15931,964Feb 18 05:44 PM
Steckel RonaldVP, OperationsJan 20Option Exercise3.941,6506,50032,989Jan 22 06:02 PM
Steckel RonaldVP, OperationsJan 20Sale9.031,65014,89831,964Jan 22 06:02 PM
Steckel RonaldVP, OperationsDec 17Option Exercise3.941,6506,5002,989Dec 18 05:28 PM
Steckel RonaldVP, OperationsDec 17Sale8.521,65014,0611,964Dec 18 05:28 PM
Steckel RonaldVP, OperationsNov 17Option Exercise3.941,6506,5002,989Nov 18 04:23 PM
Steckel RonaldVP, OperationsNov 17Sale8.281,65013,6671,964Nov 18 04:23 PM
Steckel RonaldVP, OperationsNov 07Option Exercise3.943,30013,0004,014Nov 12 04:05 PM
Steckel RonaldVP, OperationsNov 07Sale8.003,30026,4001,964Nov 12 04:05 PM
MOORE WILLIAM MDirectorNov 06Buy7.794,80037,392102,396Nov 06 07:38 PM
MOORE WILLIAM MDirectorNov 05Buy7.752001,55097,596Nov 06 07:38 PM
BlueLine Catalyst Fund IX, L.PDirectorOct 12Buy8.1117,237139,7922,559,122Nov 12 05:57 PM
BlueLine Catalyst Fund IX, L.PDirectorOct 10Buy8.0212,798102,6402,541,885Nov 12 05:57 PM
BlueLine Catalyst Fund IX, L.PDirectorOct 07Buy8.004,05032,4002,529,087Nov 07 07:37 PM
BlueLine Catalyst Fund IX, L.PDirectorOct 06Buy7.782,73221,2552,525,037Nov 07 07:37 PM